Skip Navigation

This Article
Right arrow FREE Full Text (Abstract-only PDF) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by van Wely, M.
Right arrow Articles by van der Veen, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Wely, M.
Right arrow Articles by van der Veen, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 18, No. 6, 1143-1149, June 2003
© 2003 European Society of Human Reproduction and Embryology

Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome: a systematic review based on a Cochrane review

M. van Wely1, N. Bayram and F. van der Veen

Center for Reproductive Medicine, Department of Obstetrics and Gynecology (H4-205), Academic Medical Center, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, The Netherlands

1 To whom correspondence should be addressed. e-mail: m.vanwely{at}amc.uva.nl

This paper is based on a Cochrane review published in The Cochrane Library, issue 2, 2001 (see www.CochraneLibrary. net for information) with permission from The Cochrane Collaboration and Update Software. Cochrane reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and The Cochrane Library should be consulted for the most recent version of the review.

This systematic review was performed to study the efficacy and safety of recombinant FSH (rFSH) versus urinary FSH (uFSH) and to compare different dose regimens of rFSH for ovulation induction in women with clomiphene-resistant polycystic ovary syndrome (PCOS). Six randomized controlled trials were included in the review, according to the principles of the Cochrane Menstrual Disorders and Subfertility Group. Three trials compared rFSH with uFSH and three trials compared two different treatment regimens of rFSH. Participants were women with clomiphene citrate-resistant PCOS. Main outcome measures were ovulation, clinical pregnancy, miscarriage, multiple pregnancy, ovarian stimulation syndrome (OSS), total gonadotrophin dose used and total duration of stimulation. Summary statistics were expressed as odds ratios. Data from the trials comparing rFSH and uFSH could be pooled. There was no evidence of a difference between rFSH and uFSH in any of the outcomes. Data from the trials comparing different dose regimens of rFSH could not be combined, and for each comparison there was insufficient evidence of a difference. More randomized clinical trials with sufficient power are necessary to estimate the difference, if one exists, between rFSH and uFSH and between different dose regimens of rFSH.

Key words: Cochrane review/ovulation induction/PCOS/rFSH/uFSH


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
M. van Wely, N. Bayram, F. van der Veen, and P. M.M. Bossuyt
Predicting ongoing pregnancy following ovulation induction with recombinant FSH in women with polycystic ovary syndrome
Hum. Reprod., July 1, 2005; 20(7): 1827 - 1832.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. van Wely, N. Bayram, F. van der Veen, and P. M.M. Bossuyt
Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant polycystic ovary syndrome
Hum. Reprod., April 1, 2005; 20(4): 900 - 905.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. Palomba, F. Orio Jr, A. Falbo, T. Russo, G. Lombardi, and F. Zullo
Are laparoscopic ovarian diathermy and gonadotropin administration the only therapeutic second-steps in clomiphene-citrate resistant women with polycystic ovary syndrome?
Hum. Reprod., November 1, 2004; 19(11): 2682 - 2683.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
M. van Wely, N. Bayram, F. van der Veen, and P. Bossuyt
Reply to: Are laparoscopic ovarian diathermy and gonadotropin administration the only therapeutic second-steps in clomiphene-citrate resistant women with polycystic ovary syndrome?
Hum. Reprod., November 1, 2004; 19(11): 2683 - 2683.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
M. van Wely, N. Bayram, P.M.M. Bossuyt, and F. van der Veen
Laparoscopic electrocautery of the ovaries versus recombinant FSH in clomiphene citrate-resistant polycystic ovary syndrome. Impact on women's health-related quality of life
Hum. Reprod., October 1, 2004; 19(10): 2244 - 2250.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. van Wely, N. Bayram, F. van der Veen, and P.M.M. Bossuyt
An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome
Hum. Reprod., August 1, 2004; 19(8): 1741 - 1745.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. van Wely, N. Bayram, and F. van der Veen
Reply: recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome
Hum. Reprod., January 1, 2004; 19(1): 218 - 218.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
A. Lass
Recombinant FSH in alternative doses or versus urinary gonadotrophins for ovulation induction in subfertility associated with polycystic ovary syndrome
Hum. Reprod., January 1, 2004; 19(1): 217 - 218.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.